SEC Form 4 · accession 0001209191-16-139548
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Lewis T Williams
Officer — President, CEO and Chairman · Director
Period of report
Sep 1, 2016
Accepted (ET)
Sep 1, 2016 · 7:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2016 | F | 7,613 | $44.74 | D | 456,715 | D | |
| Common Stock | Sep 1, 2016 | G | 22,416 | $44.74 | D | 434,299 | D |
Table II — derivative securities
No Table II lines on this filing.